Koyfin Home > Directory > Health Care > Inovio Pharma > Long-Term Debt

Inovio Pharma Long-Term Debt Chart (INO)

Inovio Pharma annual/quarterly Long-Term Debt from 2019 to 2020.
  • Inovio Pharma Long-Term Debt for the quarter ending June 06, 2020 was $80m a 11.93% increase of 9m year over year
  • Inovio Pharma Long-Term Debt for the last 12 months ending June 06, 2020 was $80m a 11.93% increase of 9m year over year
Other Cash Flow Metrics:
  • Inovio Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a 27.23% decrease of -5m year over year
  • Inovio Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-18m a 95.05% decrease of -17m year over year
  • Inovio Pharma Total Revenue for the quarter ending September 09, 2018 was $2m a -339.17% decrease of -7m year over year
View Chart On Koyfin

Quarterly INO Long-Term Debt Data

06/2020$80m
03/2020$77m
12/2019$77m
09/2019$70m
06/2019$63m
03/2019$61m

Annual INO Long-Term Debt Data

2019$77m